Anzeige
Meldung des Tages: Insider kaufen kräftig zu – 421.670 CAD an Käufen, während Silber $88 erreicht

ImmunityBio News

Aktie
WKN:  A2QQ2E ISIN:  US45256X1037 US-Symbol:  IBRX Branche:  Biotechnologie Land:  USA
8,385 $
+0,56 $
+7,16%
7,3445 € 13.03.26
Depot/Watchlist
Marktkapitalisierung *
1,55 Mrd. €
Streubesitz
18,77%
KGV
-4,88
Index-Zuordnung
-

ImmunityBio News

09.03.26 - PR Newswire
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-​Unresponsive NMIBC with Papillary Disease Following Agency Review of ...
25.02.26 - PR Newswire
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
Immuno-​Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 PR Newswire
19.02.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX PR Newswire
17.02.26 - PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire
17.02.26 - PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire
12.02.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX PR Newswire
29.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX PR Newswire
28.01.26 - PR Newswire
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
Late-​Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment PR Newswire
28.01.26 - PR Newswire
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
Late-​Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment PR Newswire
20.01.26 - WH Selfinvest
Fiserv, Western Digital & ImmunityBio: Lohnen sich diese Aktien jetzt?
20.01.26 - wallstreetONLINE Redaktion
Der nächste Crowd-Trade?: Vom Nischen-Biotech zum Retail-Hype: Diese Aktie dreht brutal auf
Eine Serie starker Studiendaten treibt ImmunityBio in einen Kaufrausch. Der Kurs schießt hoch, das Volumen explodiert – und Leerverkäufer stehen plötzlich im Regen.ImmunityBio ...
16.01.26 - PR Newswire
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape PR Newswire
16.09.25 - PR Newswire
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals PR Newswire
16.09.25 - PR Newswire
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals PR Newswire
13.09.25 - wallstreetONLINE Redaktion
Meme-Aktien-Alarm: JPMorgan warnt bei diesen vier Meme-Aktien vor Short-Squeeze
JPMorgan warnt: Vier neue Meme-​Aktien locken Kleinanleger und Short-​Seller zugleich. Droht der nächste Short-​Squeeze nach GameStop & Co.? Das sind die Kandidaten.Die Wall ...
28.08.25 - PR Newswire
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone PR Newswire
28.08.25 - PR Newswire
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone PR Newswire
09.07.25 - PR Newswire
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Breaking Through: Systemic Genetic Medicines for Hard-​to-Treat Cancers PR Newswire
09.07.25 - PR Newswire
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Breaking Through: Systemic Genetic Medicines for Hard-​to-Treat Cancers PR Newswire
12.06.25 - PR Newswire
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry PR Newswire

Newssuche

Videos

newspaper
13.03.26 -4,81%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »